Accurate prediction of genetic disorders from DNA mutation data is a critical challenge in computational genomics due to complex mutation patterns and nonlinear genotype-phenotype relationships. This paper proposes a hybrid classical-quantum learning framework that integrates unified sequence graph feature encoding, transformer-based contextual modeling, dual-attention representation refinement, orangutan-based parameter optimization, and a variational quantum classifier for enhanced genetic disorder prediction. The proposed approach leverages hybrid classical-quantum learning to enhance discriminative feature learning in compact latent spaces. Experiments conducted on the Genetic Disorder Prediction Dataset demonstrate that the proposed framework achieves 94.10% accuracy, 93.60% precision, 93.40% F1-score, 92.00% Matthews correlation coefficient, and 96.70% AUC, outperforming existing machine learning and deep learning methods. Ablation studies confirm the contribution of each architectural component, while quantum circuit analysis identifies an optimal configuration of 8 qubits with a circuit depth of 4. Noise sensitivity and inference-time evaluations further indicate that the proposed model remains robust under realistic quantum noise conditions with only a marginal computational overhead. These results validate the effectiveness and practical feasibility of hybrid classical-quantum learning for genomic prediction tasks and highlight its potential for future quantum-assisted bioinformatics and precision medicine applications.
Accurate prediction of genetic disorders from DNA mutation data is a critical challenge in computational genomics due to complex mutation patterns and nonlinear genotype-phenotype relationships. This paper proposes a hybrid classical-quantum learning framework that integrates unified sequence graph feature encoding, transformer-based contextual modeling, dual-attention representation refinement, orangutan-based parameter optimization, and a variational quantum classifier for enhanced genetic disorder prediction. The proposed approach leverages hybrid classical-quantum learning to enhance discriminative feature learning in compact latent spaces. Experiments conducted on the Genetic Disorder Prediction Dataset demonstrate that the proposed framework achieves 94.10% accuracy, 93.60% precision, 93.40% F1-score, 92.00% Matthews correlation coefficient, and 96.70% AUC, outperforming existing machine learning and deep learning methods. Ablation studies confirm the contribution of each architectural component, while quantum circuit analysis identifies an optimal configuration of 8 qubits with a circuit depth of 4. Noise sensitivity and inference-time evaluations further indicate that the proposed model remains robust under realistic quantum noise conditions with only a marginal computational overhead. These results validate the effectiveness and practical feasibility of hybrid classical-quantum learning for genomic prediction tasks and highlight its potential for future quantum-assisted bioinformatics and precision medicine applications.
Accurate prediction of genetic disorders from DNA mutation data is a critical challenge in computational genomics due to complex mutation patterns and nonlinear genotype–phenotype relationships. This paper proposes a hybrid classical–quantum learning framework that integrates unified sequence graph feature encoding, transformer-based contextual modeling, dual-attention representation refinement, orangutan-based parameter optimization, and a variational quantum classifier for enhanced genetic disorder prediction. The proposed approach leverages hybrid classical–quantum learning to enhance discriminative feature learning in compact latent spaces. Experiments conducted on the Genetic Disorder Prediction Dataset demonstrate that the proposed framework achieves 94.10% accuracy, 93.60% precision, 93.40% F1-score, 92.00% Matthews correlation coefficient, and 96.70% AUC, outperforming existing machine learning and deep learning methods. Ablation studies confirm the contribution of each architectural component, while quantum circuit analysis identifies an optimal configuration of 8 qubits with a circuit depth of 4. Noise sensitivity and inference-time evaluations further indicate that the proposed model remains robust under realistic quantum noise conditions with only a marginal computational overhead. These results validate the effectiveness and practical feasibility of hybrid classical–quantum learning for genomic prediction tasks and highlight its potential for future quantum-assisted bioinformatics and precision medicine applications.
Finding drug-like molecules is a time- and money-consuming task that requires virtual screening techniques capable of accurately representing non-linear intermolecular relationships. Classical ML models usually consider molecular graphs or SMILES sequences, but cannot jointly exploit both structural and sequential information, let alone simultaneously. Of greater importance, numerous deep learning methods are hindered by poor generalisation, black-box predictions, and inadequate interpretability, reducing their feasibility for application in real-life drug discovery pipelines. In this paper, we present QDrugDiscoverAI, a hybrid quantum–classical deep learning framework for predicting molecular properties and optimising molecules to overcome these challenges. We present a framework for multimodal molecular representation learning that combines graph attention networks and transformer-based sequence encoders with variational quantum circuits to increase expressive capacity within a single architecture. It implements a dual-stream representation-learning mechanism with a multimodal feature fusion layer. It includes an explainability module that uses attention weights and SHAP values to identify substructures that contribute to model predictions and enhance interpretability. Moreover, QDrugDiscoverAI also includes a quantum–assisted reinforcement-learning module for a molecule-optimisation workflow, enabling more efficient exploration of the chemical design space while leveraging the controllability of quantum simulation. The experiments on three benchmark datasets, i.e., Lipophilicity, HIV, and BBBP, show improvements of 12.4%, 9.6%, and 11.1% in accuracy, AUC, and F1-score, respectively, over the matched classical and unimodal baselines. Quantitative evaluation of quantum components and fusion strategies is also conducted through ablation studies to demonstrate their roles further. In summary, the framework proposed serves as a systematic integration of interpretable hybrid learning, showing one way it could be organised to become increasingly efficient, and demonstrating the advantage of using quantum-simulated components to enhance classical deep learning models for exploration and predictive performance in drug discovery workflows. The implementation code and supporting scripts for the proposed QDrugDiscoverAI framework are publicly available at: https://github.com/Sripada-RamaSree/QuantumDrugAI
The rapid advancements in genomics and the availability of large-scale genetic datasets have revolutionized our understanding of genetic diseases. However, the complexity and high dimensionality of genomic data pose significant computational challenges for classical machine learning (ML) algorithms. Quantum machine learning (QML), an emerging interdisciplinary field that combines quantum computing with ML techniques, offers a promising solution to address these challenges. This paper explores the application of QML algorithms for diagnosing genetic diseases by leveraging the unique properties of quantum computing, such as superposition, entanglement, and quantum parallelism. A novel hybrid quantum-classical approach is proposed to enhance the accuracy and efficiency of disease diagnosis using genomic datasets. The methodology involves encoding genetic data into quantum states, applying quantum-enhanced feature selection and classification algorithms, and validating the results on publicly available datasets, such as the UK Biobank and the Cancer Genome Atlas (TCGA). Experimental results demonstrate that the proposed QML framework achieves higher classification accuracy and faster computation times compared to classical counterparts. Equations, tables, and charts are used to illustrate the effectiveness of the approach. This research highlights the transformative potential of QML in precision medicine and lays the groundwork for future investigations into quantum-enabled healthcare solutions.
Quantum computing has emerged as a promising technology for solving complex computational problems by leveraging the principles of quantum mechanics, including superposition and entanglement. Integrating quantum computing with classical machine learning offers a potential approach to improving learning capabilities and classification performance. This research proposes a Hybrid Quantum-Classical Machine Learning Framework that combines classical data preprocessing techniques with parameterized quantum circuits to perform classification tasks. The framework uses classical machine learning components for feature preprocessing and data encoding, while a variational quantum circuit extracts quantum representations of the input data. A classical optimizer updates the quantum circuit parameters iteratively to minimize a predefined classification loss function. The proposed framework is evaluated using benchmark classification datasets and compared with conventional machine learning models, including Support Vector Machines, Logistic Regression, and classical Neural Networks. Performance is assessed using accuracy, precision, recall, F1-score, computational cost, and training time. Experiments also investigate the effects of circuit depth, feature selection, and simulated quantum noise on classification performance. The framework is implemented using the PennyLane quantum simulation library alongside standard machine learning libraries. The study identifies the conditions under which hybrid quantum-classical learning can provide competitive classification performance and determines the practical limitations of current quantum machine learning approaches. The findings contribute to a better understanding of the effectiveness, scalability, and feasibility of hybrid quantum classical models for realworld classification problems.
Accurate classification of microscopic blood cells is still a critical task in medical image analysis, where subtle variations and limited data can challenge conventional deep learning models. As such, we investigate in this work the potential of Hybrid Quantum-Classical Neural Networks (HQNNs) to enhance feature representation and improve classification performance in this domain. We propose a modular architecture combining a pre-trained ResNet-50 backbone with a low-dimensional latent bottleneck and a variational quantum circuit, enabling a direct comparison between quantum-enhanced and purely classical transformation mechanisms. To isolate the contribution of the quantum component, we evaluate three architectures: a HQNN model, a Classical Matched Model with an additional nonlinear transformation layer of comparable capacity, and a baseline model without an intermediate transformation stage. Experiments conducted on two publicly available blood cell datasets, namely the Blood Cell Images dataset and the PBC dataset, demonstrate that HQNNs consistently achieve superior or more balanced performance across evaluation metrics. In the Blood Cell Images Dataset, the proposed approach improves macro F1-score by up to 3.7% compared to classical baselines, while improving the F1-score from 98.54% to 98.69% in the more challenging 8-class scenario with near-saturated performance. Additional evaluation on IBM quantum hardware shows that the model remains robust under noise, with only a modest performance degradation relative to simulated results. These results indicate that quantum feature transformations can enhance discriminative representations, particularly in challenging classification scenarios, and highlight the practical potential of HQNN models for medical imaging tasks.
The rapid expansion of clinical data in modern healthcare requires analytical systems capable of uncovering intricate patterns and supporting accurate diagnostic decisions. Quantum machine learning (QML) offers significant potential for modeling higher-order feature interactions and accelerating computation beyond classical approaches. This paper introduces an improved hybrid architecture that fuses an inception-based attentional VGG (IAV) network with a quantum variational classifier (QVC) constructed using parameterized quantum circuits (PQCs). The framework begins with min-max normalization to stabilize heterogeneous clinical attributes and enhance training convergence. Deep discriminative features are then extracted through the IAV model, followed by quantum-driven classification using variational layers optimized by classical routines. The MIMIC-III clinical dataset is employed to validate the proposed system on large-scale healthcare records. Performance is measured using accuracy, precision, recall, and F1-score. The enhanced hybrid model achieves 97.28% accuracy, 97.16% precision, 96.65% recall, and a 97.38% F1-score, surpassing established methods including support vector machine (SVM) (89.23%), quantum support vector machine (QSVM) (90.13%), and QVKSVM (97.34%). The findings confirm that integrating deep learning with quantum variational optimization strengthens scalability, reduces computational overhead, and establishes a powerful foundation for next-generation healthcare analytics.